Listing Type:   | International Debt |
Listing Status:   | Delisted |
Listed:   | 13 Apr 2018 |
Delisted:   | 13 Mar 2020 |
Myovant Sciences Ltd. is a Bermuda exempted company limited by shares with registration number 51163. Its registered office is Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda. The Issuer is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women’s health and endocrine diseases.
The Issuer’s common shares are publicly traded and listed on the New York Stock Exchange under the symbol “MYOV”. The Notes will be fully and unconditionally guaranteed, on a secured basis, by each of the Issuer's wholly owned subsidiaries Myovant Holdings Limited, Myovant Sciences, Inc., Myovant Sciences GmbH, and Myovant Sciences Ireland Limited (the “Guarantors”).
Myovant Sciences Ltd., US$60,000,000 Secured Senior Notes Program - Listed 13 April 2018;
Myovant Sciences Ltd., US$60,000,000 - 15% Secured Senior Notes Due 16 October 2023; pursuant to its program.
Disclaimer and Privacy Policy Complaints Policy
Copyright © 2024 by Bermuda Stock Exchange. All rights reserved!
Questions or requests for information can be emailed to info@bsx.com